OTC · Medical - Devices

ImpediMed Limited (IPDQF) Stock

$0.00 OTC: IPDQF Healthcare

ImpediMed Limited is a medical technology firm that specializes in software solutions. The company is involved in the creation, production, and global distribution of sophisticated bioimpedance spectroscopy (BIS) equipment and its accompanying software applications, serving markets in Australia, North America, and beyond.

Valuation

MetricValue
Price$0.00
Market Cap$6.91M
P/E Ratio-0.37
P/B Ratio1.18
P/S Ratio0.85
EPS (TTM)$-0.01
52-Week High$0.04
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-117.92%
ROA-35.93%
ROCE-70.68%
Gross Margin86.14%
Operating Margin-144.54%
Net Margin-171.25%
Debt/Equity2.39
Current Ratio3.74

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$10.0M$11.0M$10.0M$13.0M
Operating Profit$-23.0M$-22.0M$-23.0M$-24.0M$-24.0M
Net Profit$-21.0M$-20.0M$-21.0M$-20.0M$-23.0M
EPS$-0.02$-0.01$-0.01$-0.01$-0.01
Op Margin-276.2%-205.2%-201.4%-241.8%-190.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$34.0M$59.0M$69.0M$47.0M$42.0M
Total Liabilities$9.0M$8.0M$8.0M$6.0M$21.0M
Cash$20.0M$41.0M$46.0M$25.0M$22.0M
Borrowings$0$0$1.0M$1.0M$14.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-13.0M$-16.0M$-18.0M$-18.0M$-15.0M
Investing Cash Flow$-7.0M$-16.0M$-18.0M$-6.0M$-2.0M
Financing Cash Flow$-1.0M$-3.0M$-1.0M$-1.0M$-2.0M
Net Cash Flow$0$21.0M$5.0M$-21.0M$-2.0M
Free Cash Flow$-16.0M$-21.0M$-24.0M$-21.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.03
EV / EBITDA-0.80
FCF Yield-84.96%
Quick Ratio3.41
Interest Coverage-7.45
Return 1Y-86.80%
Return 3Y-97.46%
Return 5Y—

Ownership

Insiders Held8.05%
Institutions Held21.05%
Institutions Float Held22.89%
Institutional HolderSharesReport Date
North Star Asset Management Inc.20,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBIXFBonus Biogroup Ltd. $0.10 +0.00% -25.29 $110.95M 0.00%
CLIFFCordlife Group Limited $0.09 -40.12% -3.10 $23.09M 0.00%
CLYYFCelyad Oncology S.A. $0.20 +0.00% 14.03 $8.95M 0.00%
CNTMFFluent Corp. $0.02 +8.33% -0.17 $10.35M 0.00%
ELXMFNova Eye Medical Limited $0.01 +0.00% -4.69 $4.08M 0.00%

About ImpediMed Limited

ImpediMed Limited is a medical technology firm that specializes in software solutions. The company is involved in the creation, production, and global distribution of sophisticated bioimpedance spectroscopy (BIS) equipment and its accompanying software applications, serving markets in Australia, North America, and beyond. Its principal offerings include: SOZO: A non-intrusive BIS device engineered for the evaluation of lymphedema and for tracking fluid levels in individuals afflicted with heart failure. SFB7: A single-channel, tetrapolar BIS instrument utilized to assess the body composition of healthy individuals. ImpediVET: Another single-channel, tetrapolar BIS device, tailored specifically for veterinary applications to measure fluid status and tissue characteristics in animals. ImpediMed primarily markets its advanced medical devices to healthcare institutions such as hospitals and clinics. The company was founded in 1999 and its headquarters are located in Pinkenba, Australia.

ImpediMed Limited (IPDQF) stock trades at $0.00 with a market capitalization of $6.91M. The stock is valued at a price-to-earnings (P/E) ratio of -0.37, price-to-book of 1.18, price-to-sales of 0.85. Over the past 52 weeks the stock has ranged between $0.00 and $0.04, and currently trades 100.0% below its 52-week high.

On profitability, ImpediMed Limited generates a return on equity (ROE) of -117.92%, return on capital employed of -70.68%, an operating margin of -144.54%, a net profit margin of -171.25%.

Official website: www.impedimed.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides